02 July 2025
Consultation is now open for the update to our clinical guideline for the prescription and monitoring of conventional systemic disease modifying anti-rheumatic drugs (csDMARDs) for people of all ages.
To submit comments, please email the completed consultation form to guidelines@rheumatology.org.uk. Comments are welcomed from individuals, groups or organisations.
The consultation period closes at 17:00 on Tuesday 5 August.
Consultation form - csDMARDs 2025
Draft Full guideline - csDMARDs
Infographic Guide
Audit tool
To submit comments, please email completed consultation form to: guidelines@rheumatology.org.uk.
If you have any issues with the readability of the draft guideline documents, please contact guidelines@rheumatology.org.uk so that an alternative version can be made available to you.